Home › Type 2 Diabetes › Texas › Cypress
Type 2 Diabetes clinical trials in Cypress, TX
4 studies for Type 2 Diabetes are looking for participants at sites in and around Cypress (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Horizon Clinical Research Group, Cypress
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Gulf Coast Clinical Research, Katy · 15 mi away
- R & H Clinical Research, Inc., Katy · 15 mi away
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Katy · 15 mi away
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecruitingPhase 3
- Prem Internal Med Asso Houston, Katy · 15 mi away
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX36 studies
- Houston, TX30 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Columbus, OH18 studies
- Dallas, TX18 studies
- Atlanta, GA17 studies
- Las Vegas, NV17 studies
- Birmingham, AL16 studies
- New York City, NY16 studies
Other studies in Cypress
- Alzheimer's Disease7 studies
- Macular Degeneration4 studies
- COPD4 studies
- Sjogren's Syndrome3 studies
- Psychomotor Agitation3 studies
- Heart Failure3 studies
- Breast Cancer3 studies
- Asthma3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.